Current status of plant-made vaccines for veterinary purposes

References

• Joensuu JJ, Niklander-Teeri V, Brandle JE. Transgenic plants for animal health: plant-made vaccine infectious disease control. Phytochem. Rev.7, 553–577 (2008).
   Google Scholar
• Fouchier RAM, Munster V, Wallensten A et al. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J. Virol.79(5), 2814–2822 (2005).
   PubMed Web of Science ®Google Scholar
• Treanor J. Influenza vaccine – outmaneuvering antigenic shift and drift. N. Engl. J. Med.350(3), 218–220 (2004).
   PubMed Web of Science ®Google Scholar
• Macken CA, Webby RJ, Bruno WJ. Genotype turnover by reassortment of replication complex genes from avian influenza A virus. J. General Virol.87(10), 2803–2815 (2006).
   PubMedGoogle Scholar
• D’Aoust MA, Lavoie PO, Couture MM et al. Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice. Plant Biotechnol. J.6(9), 930–940 (2008).
   PubMed Web of Science ®Google Scholar
• Shoji Y, Chichester JA, Bi H et al. Plant-expressed HA as a seasonal influenza vaccine candidate. Vaccine26(23), 2930–2934 (2008).
   PubMed Web of Science ®Google Scholar
• Shoji Y, Bi H, Musiychuk K et al. Plant-derived hemagglutinin protects ferrets against challenge infection with the A/Indonesia/05/05 strain of avian influenza. Vaccine27(7), 1087–1092 (2009).
   PubMed Web of Science ®Google Scholar
• Spitsin S, Andrianov V, Pogrebnyak N et al. Immunological assessment of plant-derived avian flu H5/HA1 variants. Vaccine27(9), 1289–1292 (2009).
   PubMed Web of Science ®Google Scholar
• Meshcheryakova YA, Eldarov MA, Migunov AI et al. Cowpea mosaic virus chimeric particles bearing the ectodomain of matrix protein 2 (M2E) of the influenza A virus: production and characterization. Appl. Mol. Biology43(4), 751–760 (2009).
   Google Scholar
• Lamb RA, Collins PL, Kolakofsky D et al.Paramyxoviridae. In: Virus Taxonomy. Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA (Eds). Elsevier, Amsterdam, The Netherlands, 655–668 (2005)
   Google Scholar
• Phillips RJ, Samson ACR, Emmerson PT. Nucleotide sequence of the 5´-terminus of Newcastle disease virus and assembly of the complete genomic sequence: agreement with the “rule of six”. Arch. Virol.143(10), 1993–2002 (1998).
   PubMed Web of Science ®Google Scholar
• Alexander DJ. Preface. In: Newcastle Disease. Alexander DJ (Ed.) Kluwer Academic Publishers, MA, USA, XI (1988).
   Google Scholar
• Mihaliak CA, Webb SR, Miller T et al. Development of plant cell produced vaccines for animal health applications. In: Proceedings of US Animal Health Association. Greensboro, NC, USA, 158–163 (2005)
   Google Scholar
• Berinstein A, Vazquez-Rovere C, Asurmendi S et al. Mucosal and systemic immunization elicited by Newcastle disease virus (NDV) transgenic plants as antigens. Vaccine23(48–49), 5583–5589 (2005).
   Web of Science ®Google Scholar
• Gómez E, Chimeno Zoth S, Carrillo E, Estela Roux M, Berinstein A. Mucosal immunity induced by orally administered transgenic plants. Immunobiology213(8), 671–675 (2008).
   Google Scholar
• Guerrero-Andrade O, Loza-Rubio E, Olivera-Flores T, Fehérvári-Bone T, Gómez-Lim MA. Expression of the Newcastle disease virus fusion protein in transgenic maize and immunological studies. Transg. Res.15(4), 455–463 (2006).
   Web of Science ®Google Scholar
• Yang CD, Liao JT, Lai CY et al. Induction of protective immunity in swine by recombinant bamboo mosaic virus expressing foot-and-mouth disease virus epitopes. BMC Biotechnol.7(1), 62 (2007).
   PubMed Web of Science ®Google Scholar
• Hahn B-S, Jeon I-S, Jung Y-J et al. Expression of hemagglutinin–neuraminidase protein of Newcastle disease virus in transgenic tobacco. Plant Biotechnol. Reports1(2), 85–92 (2007).
   Web of Science ®Google Scholar
• Gómez E, Zoth SC, Asurmendi S, Vázquez Rovere C, Berinstein A. Expression of hemagglutinin–neuraminidase glycoprotein of Newcastle disease virus in agroinfiltrated Nicotiana benthamiana plants. J. Biotechnol.144(4), 337–340 (2009).
   Google Scholar
• Doel TR. FMD vaccines. Virus Res.91(1), 81–99 (2003).
   PubMed Web of Science ®Google Scholar
• Alexandersen S, Zhang Z, Donaldson AI, Garland AJM. The pathogenesis and diagnosis of foot-and-mouth disease. J. Comparative Pathol.129(1), 1–36 (2003).
   PubMed Web of Science ®Google Scholar
• Thompson D, Muriel P, Russell D et al. Economic costs of the foot and mouth disease outbreak in the United Kingdom in 2001. Rev. Off. Int. Epizoot.21(3), 675–687 (2002).
   PubMed Web of Science ®Google Scholar
• Blake A, Sinclair MT, Sugiyarto G. Quantifying the impact of foot and mouth disease on tourism and the UK economy. Tourism Economics19(4), 449–465 (2003).
   Google Scholar
• Mackay DKJ, Forsyth MA, Davies PR et al. Differentiating infection from vaccination in foot-and-mouth disease using a panel of recombinant, non-structural proteins in ELISA. Vaccine16(5), 446–459 (1998).
   PubMed Web of Science ®Google Scholar
• Francis MJ, Hastings GZ, Brown F, McDermed J, Lu YA, Tam JP. Immunological evaluation of the multiple antigen peptide (MAP) system using the major immunogenic site of foot-and-mouth disease virus. Immunology73(3), 249–254 (1991).
   PubMed Web of Science ®Google Scholar
• Berinstein A, Tami C, Taboga O, Smitsaart E, Carrillo E. Protective immunity against foot-and-mouth disease virus induced by a recombinant vaccinia virus. Vaccine18(21), 2231–2238 (2000).
   Google Scholar
• Hammond RW, Nemchinov LG. Plant production of veterinary vaccines and therapeutics. Plant-Produced Microb. Vaccines332, 79-102 (2009).
   Google Scholar
• Usha R, Rohll JB, Spall VE et al. Expression of an animal virus antigenic site on the surface of a plant virus particle. Virology197, 366–374 (1993).
   PubMed Web of Science ®Google Scholar
• Wigdorovitz A, Perez Filgueira DM, Robertson N et al. Protection of mice against challenge with foot and mouth disease virus (FMDV) by immunization with foliar extracts from plants infected with recombinant tobacco mosaic virus expressing the FMDV structural protein VP1. Virology264(1), 85–91 (1999).
   PubMed Web of Science ®Google Scholar
• Carrillo C, Wigdorovitz A, Oliveros JC et al. Protective immune response to foot-and-mouth disease virus with VP1 expressed in transgenic plants. J. Virol.72(2), 1688–1690 (1998).
   PubMed Web of Science ®Google Scholar
• Wigdorovitz A, Carrillo C, Dus Santos MJ et al. Induction of a protective antibody response to foot and mouth disease virus in mice following oral or parenteral immunization with alfalfa rransgenic plants expressing the viral structural protein VP1. Virology255(2), 347–353 (1999).
   PubMed Web of Science ®Google Scholar
• Carrillo C, Wigdorovitz A, Trono K et al. Induction of a virus-specific antibody response to foot and mouth disease virus using the structural protein VP1 expressed in transgenic potato plants. Viral Immunol.14(1), 49–57 (2001).
   PubMed Web of Science ®Google Scholar
• Huang Y, Liang W, Wang Y et al. Immunogenicity of the epitope of the foot-and-mouth disease virus fused with a hepatitis B core protein as expressed in transgenic tobacco. Viral Immunol.18, 668–677 (2005).
   PubMed Web of Science ®Google Scholar
• Pan L, Zhang Y, Wang Y et al. Foliar extracts from transgenic tomato plants expressing the structural polyprotein, P1–2A, and protease, 3C, from foot-and-mouth disease virus elicit a protective response in guinea pigs. Vet. Immunol. Immunopathol.121(1–2), 83–90 (2008).
   PubMed Web of Science ®Google Scholar
• Li Y, Sun M, Liu J, Yang Z, Zhang Z, Shen G. High expression of foot-and-mouth disease virus structural protein VP1 in tobacco chloroplasts. Plant Cell Reports25(4), 329–333 (2006).
   Google Scholar
• Lentz EM, Segretin ME, Morgenfeld MM et al. High expression level of a foot and mouth disease virus epitope in tobacco transplastomic plants. Planta231(2), 387–395 (2010).
   PubMedGoogle Scholar
• Dus Santos MJ, Carrillo C, Ardila F et al. Development of transgenic alfalfa plants containing the foot and mouth disease virus structural polyprotein gene P1 and its utilization as an experimental immunogen. Vaccine23(15), 1838–1843 (2005).
   PubMed Web of Science ®Google Scholar
• Nagy B, Fekete PZ. Enterotoxigenic Escherichia coli in veterinary medicine. Int. J. Med. Microbiol.295(6–7), 443–454 (2005).
   PubMed Web of Science ®Google Scholar
• de Haan L, Verweij WR, Feil IK et al. Role of GM1 binding in the mucosal immunogenicity and adjuvant activity of the Escherichia coli heat-labile enterotoxin and its B subunit. Immunology94(3), 424–430 (1998).
   PubMed Web of Science ®Google Scholar
• Clements JD, Hartzog NM, Lyon FL. Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens. Vaccine6(3), 269–277 (1988).
   PubMed Web of Science ®Google Scholar
• Lebens M, Shahabi V, Backstrom M, Houze T, Lindblad N, Holmgren J. Synthesis of hybrid molecules between heat-labile enterotoxin and cholera toxin B subunits: potential for use in a broad-spectrum vaccine. Infect. Immun.64(6), 2144–2150 (1996).
   PubMed Web of Science ®Google Scholar
• Rigano MM, Sala F, Arntzen CJ, Walmsley AM. Targeting of plant-derived vaccine antigens to immunoresponsive mucosal sites. Vaccine21(7–8), 809–811 (2003).
   Google Scholar
• Haq TA, Mason HS, Clements JD, Arntzen CJ. Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science268(5211), 714–716 (1995).
   PubMed Web of Science ®Google Scholar
• Mason HS, Haq TA, Clements JD, Arntzen CJ. Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene. Vaccine16(13), 1336–1343 (1998).
   PubMed Web of Science ®Google Scholar
• Lauterslager TGM, Florack DEA, van der Wal TJ et al. Oral immunisation of naive and primed animals with transgenic potato tubers expressing LT-B. Vaccine19(17–19), 2749–2755 (2001).
   PubMed Web of Science ®Google Scholar
• Lamphear BJ, Streatfield SJ, Jilka JM et al. Delivery of subunit vaccines in maize seed. J. Control. Release85(1–3), 169–180 (2002).
   PubMed Web of Science ®Google Scholar
• Streatfield S, Mayor J, Barker D et al. Development of an edible subunit vaccine in corn against enterotoxigenic strains of Escherichia coli. In Vitro Cell. Dev. Biol. Plant38(1), 11–17 (2002).
   Web of Science ®Google Scholar
• Streatfield SJ, Lane JR, Brooks CA et al. Corn as a production system for human and animal vaccines. Vaccine21, 812–815 (2003).
   PubMed Web of Science ®Google Scholar
• Chikwamba R, McMurray J, Shou H et al. Expression of a synthetic E. coli heat-labile enterotoxin B sub-unit (LT-B) in maize. Mol. Breeding10(4), 253–265 (2002).
   Web of Science ®Google Scholar
• Karaman S, Cunnick J, Wang K. Analysis of immune response in young and aged mice vaccinated with corn-derived antigen against Escherichia coli heat-labile enterotoxin. Mol. Biotechnol.32(1), 31–42 (2006).
   Google Scholar
• Moravec T, Schmidt MA, Herman EM, Woodford-Thomas T. Production of Escherichia coli heat labile toxin (LT) B subunit in soybean seed and analysis of its immunogenicity as an oral vaccine. Vaccine25(9), 1647–1657 (2007).
   PubMed Web of Science ®Google Scholar
• Stoger E, Ma JKC, Fischer R, Christou P. Sowing the seeds of success: pharmaceutical proteins from plants. Curr. Opin. Biotechnol.16(2), 167–173 (2005).
   PubMed Web of Science ®Google Scholar
• Kang T-J, Loc N-H, Jang M-O et al. Expression of the B subunit of E. coli heat-labile enterotoxin in the chloroplasts of plants and its characterization. Transgenic Res.12(6), 683–691 (2003).
   PubMed Web of Science ®Google Scholar
• Kang T-J, Lee W-S, Choi E-G, Kim J-W, Kim B-G, Yang M-S. Mass production of somatic embryos expressing Escherichia coli heat-labile enterotoxin B subunit in Siberian ginseng. J. Biotechnol.121(2), 124–133 (2006).
   PubMed Web of Science ®Google Scholar
• Kim T-G, Kim M-Y, Kim B-G et al. Synthesis and assembly of Escherichia coli heat-labile enterotoxin B subunit in transgenic lettuce (Lactuca sativa). Protein Expr. Purif.51(1), 22–27 (2007).
   Google Scholar
• Oszvald M, Kang T-J, Tomoskozi S et al. Expression of a synthetic neutralizing epitope of porcine epidemic diarrhea virus fused with synthetic B subunit of Escherichia coli heat labile enterotoxin in rice endosperm. Mol. Biotechnol.35(3), 215–224 (2007).
   Google Scholar
• Rosales-Mendoza S, Soria-Guerra R, de Jesús Olivera-Flores M et al. Expression of Escherichia coli heat-labile enterotoxin B subunit (LTB) in carrot (Daucus carota L.). Plant Cell Reports26(7), 969–976 (2007).
   Google Scholar
• Rosales-Mendoza S, Soria-Guerra RE, Lopez-Revilla R, Moreno-Fierros L, Alpuche-Solis AG. Ingestion of transgenic carrots expressing the Escherichia coli heat-labile enterotoxin B subunit protects mice against cholera toxin challenge. Plant Cell Reports27(1), 79–84 (2008).
   PubMed Web of Science ®Google Scholar
• Ravin NV, Kuprianov VV, Zamchuk LA et al. Highly efficient expression of Escherichia coli heat-labile enterotoxin B subunit in plants using potato virus X-based vector. Biochemistry (Moscow)73(10), 1108–1113 (2008).
   Google Scholar
• Walmsley AM, Alvarez ML, Jin Y et al. Expression of the B subunit of Escherichia coli heat-labile enterotoxin as a fusion protein in transgenic tomato. Plant Cell Reports21(10), 1020–1026 (2003).
   PubMed Web of Science ®Google Scholar
• Rigano MM, Alvarez ML, Pinkhasov J et al. Production of a fusion protein consisting of the enterotoxigenic Escherichia coli heat-labile toxin B subunit and a tuberculosis antigen in Arabidopsis thaliana. Plant Cell Reports22(7), 502–508 (2004).
   PubMed Web of Science ®Google Scholar
• Rigano MM, Dreitz S, Kipnis A-P, Izzo AA, Walmsley AM. Oral immunogenicity of a plant-made, subunit, tuberculosis vaccine. Vaccine24(5), 691–695 (2006).
   PubMed Web of Science ®Google Scholar
• Zhang X, Yuan Z, Guo X, Li J, Li Z, Wang Q. Expression of Chlamydophila psittaci MOMP heat-labile toxin B subunit fusion gene in transgenic rice. Biologicals36, 296–302 (2008).
   Google Scholar
• Zhang X, Yuan Z, Duan Q, Zhu H, Yu H, Wang Q. Mucosal immunity in mice induced by orally administered transgenic rice. Vaccine27(10), 1596–1600 (2009).
   Google Scholar
• Sim J-S, Pak H-K, Kim D-S, Lee S-B, Kim Y-H, Hahn B-S. Expression and characterization of synthetic heat-labile enterotoxin B subunit and hemagglutinin–neuraminidase-neutralizing epitope fusion protein in Escherichia coli and tobacco chloroplasts. Plant Mol. Biol. Report.27(3), 388–399 (2009).
   Google Scholar
• Van den Broeck W, Cox E, Oudega B, Goddeeris BM. The F4 fimbrial antigen of Escherichia coli and its receptors. Vet. Microbiol.71(3–4), 223–244 (2000).
   PubMed Web of Science ®Google Scholar
• Joensuu J, Kotiaho M, Riipi T et al. Fimbrial subunit protein FaeG expressed in transgenic tobacco inhibits the binding of F4ac enterotoxigenic Escherichia coli to porcine enterocytes. Transgenic Res.13(3), 295–298 (2004).
   PubMed Web of Science ®Google Scholar
• Joensuu J, Kotiaho M, Teeri T et al. Glycosylated F4 (K88) fimbrial adhesin FaeG expressed in barley endosperm induces ETEC-neutralizing antibodies in mice. Transgenic Res.15(3), 359–373 (2006).
   Google Scholar
• Joensuu JJ, Verdonck F, Ehrström A et al. F4 (K88) fimbrial adhesin FaeG expressed in alfalfa reduces F4+ enterotoxigenic Escherichia coli excretion in weaned piglets. Vaccine24(13), 2387–2394 (2006).
   Google Scholar
• Piller K, Clemente T, Jun S et al. Expression and immunogenicity of an Escherichia coli K99 fimbriae subunit antigen in soybean. Planta222(1), 6–18 (2005).
   PubMed Web of Science ®Google Scholar
• Drake PMW, Barbi T, Sexton A et al. Development of rhizosecretion as a production system for recombinant proteins from hydroponic cultivated tobacco. FASEB J.23, 1–9 (2009).
   Google Scholar
• Floss DM, Falkenburg D, Conrad U. Production of vaccines and therapeutic antibodies for veterinary applications in transgenic plants: an overview. Transgenic Res.16, 315–332 (2007).
   Google Scholar
• Streatfield SJ, Howard JA. Plant-based vaccines. Int. J. Parasitol.33, 479–493 (2003).
   PubMed Web of Science ®Google Scholar
• Kirk DD, McIntosh K, Walmsley AM, Peterson RKD. Risk analysis for plant-made vaccines. Transgenic Res.14(4), 449–462 (2005).
   PubMed Web of Science ®Google Scholar
• Alvarez ML, Pinyerd HL, Topal E, Cardineau GA. P19-dependent and P19 independent reversion of F1-V gene silencing in tomato. Plant Mol. Biol.68, 61–79 (2008).
   Google Scholar
• Daniell H, Singh ND, Mason H, Streatfield SJ. Plant-made vaccine antigens and biopharmaceuticals. Trends Plant Sci.14(12), 669–679 (2009).
   PubMed Web of Science ®Google Scholar
• Molina A, Hervás-Stubbs S, Daniell H, Mingo-Castel AM, Veramendi J. High-yield expression of a viral peptide animal vaccine in transgenic tobacco chloroplasts. Plant Biotechnol. J.2, 141–153 (2004).
   PubMed Web of Science ®Google Scholar
• Daniell H, Lee S-B, Panchal T, Wiebe PO. Expression of the native cholera toxin B subunit gene and assembly as functional oligomers in transgenic chloroplasts. J. Mol. Biol.311, 1001–1009 (2001).
   PubMed Web of Science ®Google Scholar
• Davoodi-Semiromi A, Schreiber M, Nalapalli S et al. Chloroplast-derived vaccine antigens confer dual immunity against cholera and malaria by oral or injectable delivery. Plant Biotechnol. J.8(2), 223–242 (2009).
   Google Scholar
• Rosales-Mendoza S, Alpuche-Solis AG, Soria-Guerra RE et al. Expression of an Escherichia coli antigenic fusion protein comprising the heat labile toxin B subunit and the heat stable toxin, and its assembly as a functional oligomer in transplastomic tobacco plants. Plant J.57(1), 45–54 (2009).
   PubMed Web of Science ®Google Scholar
• Rybicki EP. Plant-produced vaccines: promise and reality. Drug Discov. Today14(1–2), 16–24 (2009).
   PubMed Web of Science ®Google Scholar
• Rybicki EP. Plant-made vaccines for humans and animals. Plant Biotechnol. J.8, 620–637 (2010).
   PubMed Web of Science ®Google Scholar
• D’Aoust MA, Couture MM, Charland N et al. The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza. Plant Biotechnol. J.8, 607–619 (2010).
   PubMed Web of Science ®Google Scholar
• Gleba Y, Klimyuk V, Marillonnet S. Viral vectors for the expression of proteins in plants. Curr. Opin. Biotechnol.18(2), 134–141 (2007).
   PubMedGoogle Scholar
• Voinnet O, Rivas S, Mestre P, Baulcombe D. An enhanced transient expression system in plants based on suppression of gene silencing by the p19 protein of tomato bushy stunt virus. Plant J.33(5), 949–956 (2003).
   PubMed Web of Science ®Google Scholar
• Johansen LK, Carrington JC. Silencing on the spot. Induction and suppression of RNA silencing in the Agrobacterium-mediated transient expression system. Plant Physiol.126(3), 930–938 (2001).
   PubMed Web of Science ®Google Scholar
• Joensuu JJ, Conley AJ, Lienemann M, Brandle JE, Linder MB, Menassa R. Hydrophobin fusions for high-level transient protein expression and purification in Nicotiana benthamiana. Plant Physiol.152(2), 622–633 (2009).
   Google Scholar
• Marillonnet S, Giritch A, Gils M, Kandzia R, Klimyuk V, Gleba Y. In planta engineering of viral RNA replicons: efficient assembly by recombination of DNA modules delivered by Agrobacterium. Proc. Natl Acad. Sci. USA101(18), 6852–6857 (2004).
   PubMed Web of Science ®Google Scholar
• Gleba Y, Klimyuk V, Marillonnet S. Magnifection – a new platform for expressing recombinant vaccines in plants. Vaccine23(17–18), 2042–2048 (2005).
   PubMed Web of Science ®Google Scholar
• Kostrzak A, Cervantes Gonzalez M, Guetard D et al. Oral administration of low doses of plant-based HBsAg induced antigen-specific IgAs and IgGs in mice, without increasing levels of regulatory T cells. Vaccine27(35), 4798–4807 (2009).
   PubMed Web of Science ®Google Scholar
• Shaaltiel Y, Bartfeld D, Hashmueli S et al. Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher’s disease using a plant cell system. Plant Biotechnol. J.5(5), 579–590 (2007).
   PubMed Web of Science ®Google Scholar
• Rybicki EP. Third International Conference on plant-based vaccines and antibodies. Expert Rev. Vaccines8(9), 1151–1155 (2009).
   Google Scholar
• Shepherd RP. Plant-based vaccines and antibodies – third international conference 15–17 June 2009, Verona Italy. IDrugs12(8), 485–488 (2009).
   Google Scholar
• Khandelwal A, Sita GL, Shaila MS. Oral immunization of cattle with hemagglutinin protein of rinderpest virus expressed in transgenic peanut induces specific immune responses. Vaccine21, 3282–3289 (2003).
   Google Scholar
• Shewen PE, Carrasco-Medina L, McBey BA, Hodgins DC. Challenges in mucosal vaccination of cattle. Vet. Immunol. Immunopathol.128, 192–198 (2009).
   PubMed Web of Science ®Google Scholar